Synthesis of Caffeic Acid Derivatives: Identification of
(E)-N-(4-Cyanobenzyl)-3-(3,4-dihydroxyphenyl)acrylamide
as an Anticancer Agent against Human Cervical Cancer Cells
作者:B. Shwetha、M.S. Sudhanva、N.R. Thimmegowda、B.M. Anil Kumar、G.S. Jagadeesha、H. Guddappa、D.S. Prasanna、R. Dinesh、R. Shobith、C.S. Anandakumar
DOI:10.14233/ajchem.2022.23726
日期:——
cell proliferation and results revealed that compound (E)-N-(4-cyanobenzyl)-3-(3,4- dihydroxyphenyl)acrylamide (SHC5) exhibited potent antiproliferative activity with 5.2 μM concentration and it is further confirmed by Hoechst/PI double staining and Annexin V/PI double staining assay. Further, compound SHC5 was screened against other cancer cell lines namely K562, Jurkat, HCT116 and MiaPaCa2 to test the
通过与不同取代胺和卤代烷偶联,合成了一系列新型天然化合物咖啡酸衍生物,以增强其抗癌活性并探索其构效关系。通过1H NMR和质谱分析确定了化合物的结构。评估化合物对 HeLa 宫颈癌细胞增殖的抑制作用,结果显示化合物 (E)-N-(4-氰基苄基)-3-(3,4-二羟基苯基)丙烯酰胺 (SHC5) 在 5.2 μM 浓度下表现出有效的抗增殖活性并通过Hoechst/PI双染和Annexin V/PI双染实验进一步证实。此外,针对其他癌细胞系(即 K562、Jurkat、HCT116 和 MiaPaCa2)筛选了化合物 SHC5,以测试该分子的特异性,结果发现无效。